A Study of the Impact of Digital Intervention on Parents/primary Caregivers' Myopia Prevention and Control Health Literacy on Preschoolers' Myopia and Physical and Mental Health
Launched by FANGBIAO TAO · Sep 30, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a digital program can help parents and caregivers learn more about preventing and managing myopia (nearsightedness) in preschool children, as well as supporting their overall physical and mental health. The researchers will compare the health of children in a group using this digital intervention with a control group that does not use the program. The goal is to see if the digital tools can effectively improve the children's eyesight and general well-being.
To be eligible for this study, children should be between 3 to 6 years old and must not have any serious vision problems or other eye diseases. Parents or caregivers interested in participating will need to be comfortable using technology, volunteer for the study, and agree to fill out a questionnaire. This study is not yet recruiting participants, but once it starts, families who join can expect to engage in helpful activities that could benefit their child's eye health and overall development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No cognitive impairment and communication impairment
- • Volunteer and sign the informed consent
- • Fill in the questionnaire
- • Skilled in using electronic equipment
- Exclusion Criteria:
- • Children with congenital glaucoma, cataract, strabismus and other congenital eye diseases
- • Children with a history of ocular trauma, eye surgery, or complications of myopia
- • Do not cooperate with the investigation
About Fangbiao Tao
Fangbiao Tao is a dedicated clinical trial sponsor with a focus on advancing medical research and innovation. With extensive expertise in therapeutic development, Fangbiao Tao aims to facilitate the progression of novel treatments through rigorous clinical studies that adhere to the highest ethical and scientific standards. Committed to improving patient outcomes, the organization collaborates with leading research institutions and healthcare professionals to ensure the successful execution of trials across various therapeutic areas. Through a meticulous approach to trial design and execution, Fangbiao Tao strives to contribute significantly to the evolving landscape of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported